Detalhe da pesquisa
1.
Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation.
J Neurooncol
; 159(3): 509-518, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35842871
2.
Leveraging external data in the design and analysis of clinical trials in neuro-oncology.
Lancet Oncol
; 22(10): e456-e465, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34592195
3.
Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma.
J Neurooncol
; 144(2): 403-407, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31325145
4.
Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation.
J Neurooncol
; 144(3): 553-562, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31377920
5.
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02.
J Neurooncol
; 136(1): 79-86, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-28988377
6.
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.
N Engl J Med
; 370(8): 709-22, 2014 Feb 20.
Artigo
Inglês
| MEDLINE | ID: mdl-24552318
7.
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.
Blood
; 125(9): 1403-10, 2015 Feb 26.
Artigo
Inglês
| MEDLINE | ID: mdl-25568347
8.
Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer.
Cancer
; 121(23): 4165-72, 2015 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26308485
9.
Radiotherapy and temozolomide for anaplastic astrocytic gliomas.
J Neurooncol
; 123(1): 129-34, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25920709
10.
LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma.
Br J Haematol
; 165(5): 640-8, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24571259
11.
Post-treatment T1 shortening in primary CNS lymphoma.
J Neurooncol
; 111(1): 25-31, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23073601
12.
A phase II trial of oral gimatecan for recurrent glioblastoma.
J Neurooncol
; 111(3): 347-53, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23232808
13.
Response assessment criteria for glioblastoma: practical adaptation and implementation in clinical trials of antiangiogenic therapy.
Curr Neurol Neurosci Rep
; 13(5): 347, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23529375
14.
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.
J Clin Oncol
; 41(32): 4945-4952, 2023 Nov 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37935104
15.
Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma.
Clin Cancer Res
; 29(20): 4186-4195, 2023 10 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37540556
16.
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older.
Cancer
; 118(22): 5595-600, 2012 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22517216
17.
Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci.
Cancer Immunol Immunother
; 61(1): 9-18, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-21811785
18.
YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma.
Ann Neurol
; 70(1): 163-9, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21391238
19.
The impact of chemotherapy on cognitive outcomes in adults with primary brain tumors.
J Neurooncol
; 108(2): 285-90, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22350376
20.
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study.
J Neurooncol
; 108(3): 491-8, 2012 07.
Artigo
Inglês
| MEDLINE | ID: mdl-22426926